Study on the Efficacy of Radiotherapy Added to Pembrolizumab in Newly Diagnosed Metastatic Head and Neck Cancers
Status:
Recruiting
Trial end date:
2029-09-15
Target enrollment:
Participant gender:
Summary
Trial evaluating the efficacy of radiotherapy added to pembrolizumab compared to
pembrolizumab alone for patients with newly diagnosed head and neck carcinoma with metastases